---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-129168"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:38:19.634613+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics dismisses KPMG, appoints Ernst & Young as auditor

## Summary
- On March 23, 2026, Audit Committee dismissed KPMG as independent registered public accounting firm.
- KPMG's reports for FY2024 and FY2025 contained no adverse opinion, disclaimer, or qualification.
- No disagreements or reportable events occurred during fiscal years 2024-2025 or interim period through March 23, 2026.
- Audit Committee approved engagement of Ernst & Young LLP as independent auditor for FY ending December 31, 2026.
- Company had no prior consultations with EY regarding accounting matters described in Item 304(a)(2).

## SEC filing metadata
- accession: 0001193125-26-129168
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312526129168/0001193125-26-129168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312526129168/d119051d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-129168
- JSON: https://secwatch.observer/filing/0001193125-26-129168.json
- Plain text: https://secwatch.observer/filing/0001193125-26-129168.txt

## Source-grounded claims
- claim_id: 311f13a3a02c3d1b3ee23554e8f68790b5b31663
  claim: Stoke Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.
  evidence_excerpt: On March 23, 2026, the Audit Committee approved the engagement of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623526/000119312526129168/0001193125-26-129168-index.htm
- claim_id: 4c92faa9afc0331ca920dbc3cd169635f22b4ad7
  claim: Stoke Therapeutics, Inc. dismissed KPMG LLP as its auditor.
  evidence_excerpt: On March 23, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Stoke Therapeutics, Inc. (the “Company”) dismissed KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623526/000119312526129168/0001193125-26-129168-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.